Search Results

You are looking at 1 - 1 of 1 items for

  • Author: F E Carrick x
  • Refine by access: All content x
Clear All Modify Search
F E Carrick School of Molecular and Biomedical Science, University of Adelaide, 5005, Australia
Biomolecular Research Institute, Parkville 3052, Australia
Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia

Search for other papers by F E Carrick in
Google Scholar
PubMed
Close
,
M G Hinds School of Molecular and Biomedical Science, University of Adelaide, 5005, Australia
Biomolecular Research Institute, Parkville 3052, Australia
Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia

Search for other papers by M G Hinds in
Google Scholar
PubMed
Close
,
K A McNeil School of Molecular and Biomedical Science, University of Adelaide, 5005, Australia
Biomolecular Research Institute, Parkville 3052, Australia
Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia

Search for other papers by K A McNeil in
Google Scholar
PubMed
Close
,
J C Wallace School of Molecular and Biomedical Science, University of Adelaide, 5005, Australia
Biomolecular Research Institute, Parkville 3052, Australia
Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia

Search for other papers by J C Wallace in
Google Scholar
PubMed
Close
,
B E Forbes School of Molecular and Biomedical Science, University of Adelaide, 5005, Australia
Biomolecular Research Institute, Parkville 3052, Australia
Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia

Search for other papers by B E Forbes in
Google Scholar
PubMed
Close
, and
R S Norton School of Molecular and Biomedical Science, University of Adelaide, 5005, Australia
Biomolecular Research Institute, Parkville 3052, Australia
Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia

Search for other papers by R S Norton in
Google Scholar
PubMed
Close

The interaction of IGF binding protein-2 (IGFBP-2) with IGF-I and -II has been investigated in solution using nuclear magnetic resonance (NMR) spectroscopy. Chemical shift perturbations in 15N- and 2H/15N-labelled IGF-I or -II upon binding to unlabelled thioredoxin-tagged bovine IGFBP-2 (Trx1–279IGFBP-2) have been monitored to identify residues involved directly in the binding interaction as well as any affected by conformational changes associated with the interaction. A key step in obtaining high-quality spectra of the complexes was the use of transverse relaxation optimised spectroscopy (TROSY) methods with partially deuterated ligands. Indeed, because the effects of conformational averaging and aggregation are eliminated in IGF-I and -II bound to IGFBP-2, the spectra of the complexes are actually superior to those of the free ligands. Comparison of our results with the crystal structure of the complex between IGF-I and an N-terminal fragment of IGFBP-5 allowed identification of those residues perturbed by the C-domain of IGFBP-2. Other perturbations, such as those of Gly19 and Asp20 of IGF-I (and the corresponding residues in IGF-II) – which are located in a reverse turn linking N-domain and C-domain interactive surfaces – are due to local conformational changes in the IGF-I and -II. Our results confirm that the C-domain of IGFBP-2 plays a key role in binding regions of IGF-I and -II that are also involved in binding to the type-1 IGF receptor and thereby blocking ligand binding to this receptor.

Free access